MYCN and neuroblastoma: The inhibitors 13-197, BI2536 and vismodegib showed cell growth inhibition with IC50 of 8.5-22.7 μM, 13-32.7 nM and 73.6-85.4 μM, against non-MYCN amplified neuroblastoma cells, respectively.